跳至主要内容
临床试验/NCT07579845
NCT07579845招募中不适用

Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress

OvationLab1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年5月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
TruDiagnostic - Epigenetic Testing

研究概览

简要总结

The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult females or males age ≥ 40 years
  • Ability to read and speak English

排除标准

  • Current use of a dietary supplement containing fulvic or humic acid
  • Current use of other binder dietary supplements, including activated charcoal, modified citrus pectin, bentonite clay, or chlorella
  • Known allergies to any ingredients in the product
  • Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks
  • Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol
  • Participants unable to provide consent

研究组 & 干预措施

Humic and Fulvic Acid Dietary Supplement

Experimental

干预措施: Humic and Fulvic Acid Dietary Supplement (Dietary Supplement)

结局指标

主要结局

TruDiagnostic - Epigenetic Testing

时间窗: Change in TruAge from baseline to 12 weeks

TruAge Test

次要结局

未报告次要终点

研究者

发起方
OvationLab
申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验